Kazantsev Aleksey G
Department of Neurology, Harvard Medical School, Disease, Massachusetts, USA.
Drug News Perspect. 2007 Oct;20(8):501-9. doi: 10.1358/dnp.2007.20.8.1157616.
There is no cure for devastating neurodegenerative disorders such as Alzheimer's, Parkinson's, Huntington's diseases or amyotrophic lateral sclerosis, which cause longterm suffering and ultimately death. Slowly progressing neurodegenerative diseases affect the lives of many thousands of patients and their families. These disorders are characterized by pathological changes in disease-specific areas of the brain. In each disease, these pathological processes lead to dysfunction and degeneration in distinct subsets of neurons. Research on neurodegenerative disorders has revealed a complex picture of cellular pathology involving abnormalities in biochemical processes, gene regulation, responses to external stimuli, etc. However, despite the differences in the clinical manifestations and selective neuronal vulnerability, on cellular and molecular levels the underlying pathological processes appear similar across different diseases, suggesting common pathways of neurodegeneration. Elucidation of the precise neurodegenerative mechanism(s) is essential for development of effective and safe therapy for these lethal human disorders.
诸如阿尔茨海默病、帕金森病、亨廷顿病或肌萎缩侧索硬化症这类毁灭性的神经退行性疾病无法治愈,它们会导致长期痛苦并最终致人死亡。进展缓慢的神经退行性疾病影响着成千上万患者及其家人的生活。这些疾病的特征是大脑特定疾病区域出现病理变化。在每种疾病中,这些病理过程都会导致不同神经元亚群功能失调和退化。对神经退行性疾病的研究揭示了一幅复杂的细胞病理学图景,涉及生化过程、基因调控、对外界刺激的反应等异常情况。然而,尽管临床表现和神经元选择性易损性存在差异,但在细胞和分子水平上,不同疾病潜在的病理过程似乎相似,这表明存在神经退行性变的共同途径。阐明精确的神经退行性机制对于开发针对这些致命人类疾病的有效且安全的治疗方法至关重要。